Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions

ITS STABILIZATION BY HYPOXIA DEPENDS ON REDOX-INDUCED CHANGES*

  1. Susana Salceda and
  2. Jaime Caro
  1. From the Cardeza Foundation for Hematologic Research, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5099

    Abstract

    The hypoxia-inducible factor 1 transcriptional activator complex (HIF-1) is involved in the activation of the erythropoietin and several other hypoxia-responsive genes. The HIF-1 complex is composed of two protein subunits: HIF-1β/ARNT (aryl hydrocarbon receptor nuclear translocator), which is constitutively expressed, and HIF-1α, which is not present in normal cells but induced under hypoxic conditions. The HIF-1α subunit is continuously synthesized and degraded under normoxic conditions, while it accumulates rapidly following exposure to low oxygen tensions. The involvement of the ubiquitin-proteasome system in the proteolytic destruction of HIF-1 in normoxia was studied by the use of specific inhibitors of the proteasome system. Lactacystin and MG-132 were found to protect the degradation of the HIF-1 complex in cells transferred from hypoxia to normoxia. The same inhibitors were able to induce HIF-1 complex formation when added to normoxic cells. Final confirmation of the involvement of the ubiquitin-proteasome system in the regulated degradation of HIF-1α was obtained by the use ofts20TG R cells, which contain a temperature-sensitive mutant of E1, the ubiquitin-activating enzyme. Exposure of ts20 cells, under normoxic conditions, to the non-permissive temperature induced a rapid and progressive accumulation of HIF-1. The effect of proteasome inhibitors on the normoxic induction of HIF-1 binding activity was mimicked by the thiol reducing agentN-(2-mercaptopropionyl)-glycine and by the oxygen radical scavenger 2-acetamidoacrylic acid. Furthermore,N-(2-mercaptopropionyl)-glycine induced gene expression as measured by the stimulation of a HIF-1-luciferase expression vector and by the induction of erythropoietin mRNA in normoxic Hep 3B cells. These last findings strongly suggest that the hypoxia induced changes in HIF-1α stability and subsequent gene activation are mediated by redox-induced changes.

    Footnotes

    • * This work was supported in part by National Institutes of Health Grant DK-34642, the Juvenile Diabetes Foundation International (195009), and Individual Training Grant 1 F32 HL 09247 (to S. S.) from the National Heart, Lung, and Blood Institute, National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • To whom correspondence should be addressed: Cardeza Foundation for Hematologic Research, 1015 Walnut St., Philadelphia, PA 19107-5099. Tel.: 215-955-7775; Fax: 215-923-3836; E-mail:CARO1{at}jeflin.tju.edu.

    • 1 The abbreviations used are: Epo, erythropoietin; HIF-1, hypoxia-inducible factor 1; ARNT, aryl hydrocarbon receptor nuclear translocator; NMPG, N-(2-mercaptopropionyl)-glycine; PAS, PER-ARNT-SIM; Ac, acetyl; Z, benzyloxycarbonyl; E1, Ub-activating enzyme.

    • 2 V. Srinivas and J. Caro, unpublished data.

    • 3 S. Salceda and J. Caro, unpublished data.

      • Received March 12, 1997.
      • Revision received June 24, 1997.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement